Pioglitazone may accelerate disease course of slowly progressive type 1 diabetes

Background It has been reported that intervention with insulin in slowly progressive type 1 diabetic (SPIDDM) patients delays the progression to an insulin‐dependent state compared to that with sulfonylureas. However, the rate of progression to SPIDDM with the use of insulin‐sensitizing agents is un...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes/metabolism research and reviews 2011-11, Vol.27 (8), p.951-953
Hauptverfasser:	Shimada, Akira, Shigihara, Toshikatsu, Okubo, Yoshiaki, Katsuki, Takeshi, Yamada, Yoshifumi, Oikawa, Yoichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age of Onset Diabetes Mellitus, Type 1 - drug therapy Disease Progression Female Glycated Hemoglobin A - metabolism Humans Hypoglycemic Agents - adverse effects Hypoglycemic Agents - therapeutic use Male metformin Metformin - therapeutic use Middle Aged pioglitazone slowly progressive type 1 diabetes Thiazolidinediones - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!